Generic drug maker Mylan has entered settlements with Pfizer concerning two drugs for treating cholesterol.
A generic version of the world’s top-selling cholesterol treatment is expected to hit the market this year, but the branded version’s manufacturer is trying to put the brakes on the launch, according to media reports.
The world of generic drugs has a big year ahead of it. Actually, it has...
Winc Design is launching its Charlie Banana brand of environmentally friendly cloth diapers and baby...
The U.S. drug market will present opportunities as well as uncertainties over the next decade,...
What’s really intriguing behind the return of a consumer division to Pfizer is the fact...